Acen Corporation
ACPIF
$0.02
-$0.02-51.00%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 147.44M | 123.42M | 137.65M | 130.36M | 146.26M |
| Total Other Revenue | 4.35M | 1.92M | 1.56M | 1.71M | 5.42M |
| Total Revenue | 151.79M | 125.34M | 139.21M | 132.07M | 151.68M |
| Cost of Revenue | 97.74M | 80.67M | 92.77M | 90.24M | 112.91M |
| Gross Profit | 54.05M | 44.67M | 46.44M | 41.83M | 38.77M |
| SG&A Expenses | 18.99M | 23.80M | 11.66M | 20.85M | 29.61M |
| Depreciation & Amortization | 16.93M | 17.10M | 16.40M | 16.14M | 14.63M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 133.66M | 121.57M | 120.84M | 127.23M | 157.15M |
| Operating Income | 18.13M | 3.78M | 18.37M | 4.84M | -5.47M |
| Income Before Tax | 37.31M | 20.63M | -25.46M | 34.28M | 23.59M |
| Income Tax Expenses | 2.35M | -51.00K | -7.02M | -1.69M | 3.89M |
| Earnings from Continuing Operations | 34.95M | 20.68M | -18.44M | 35.97M | 19.69M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -1.13M | -2.68M | -2.66M | -2.32M | 1.19M |
| Net Income | 33.82M | 18.00M | -21.10M | 33.65M | 20.89M |
| EBIT | 18.13M | 3.78M | 18.37M | 4.84M | -5.47M |
| EBITDA | 33.65M | 18.96M | 32.99M | 19.31M | 3.61M |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 39.82B | 39.68B | 39.68B | 39.68B | 39.68B |
| Average Diluted Shares Outstanding | 39.82B | 39.68B | 39.68B | 39.68B | 39.68B |
| Dividend Per Share | -- | -- | -- | -- | 0.00 |
| Payout Ratio | 64.22% | -- | -- | 32.76% | 95.98% |